Experimental oncology.

ISSN 1812-9269PH Akademperiodyka of the NAS of UkraineUkraine
ScopusMEDLINEEmbasePubMedPMCSCImagoMatched via identifier

Journal overview

Titles
Experimental Oncology
Exp. Oncol. (abbreviated)
Experimental oncology.
Exp Oncol (abbreviated)
ISSN
1812-9269
eISSN
2312-8852
NLM ID
101230541
Publisher
PH Akademperiodyka of the NAS of Ukraine
Morion LLC
Kyiv : Morion, [2004]-
Country
Language
ENG
English, Russian

Indexing & coverage

Scopus
Currently indexed

Scopus's Sources record lists this journal as active.

Indexing history
Coverage
1984–2026
Indexing services (MEDLINE, Embase)
MEDLINECurrently indexedEmbaseListed

Embase's Active journals record lists this journal as active.

Bibliographic inclusion (PubMed)
PubMedIncluded
Full-text availability (PMC — not an indexing service)
PMCNot found in this source

Metrics

JIF
Not available
SCImago Journal Rank (SJR) — 2025

Source: SCImago Journal & Country Rank — 2025 dataset. SJR is a metric published by SCImago, presented here as reported.

SJR
0.261
Best Quartile
Q4
H-index
52
Subject categories
  • Cancer Research — Q4
  • Oncology — Q4
More metrics
Coverage
1984–2025
Country
Ukraine
Region
Eastern Europe
Publisher
Morion LLC
Open Access
Yes
Open Access (Diamond)
No
Total documents (current year)
33
Total documents (3 years)
172
Total references
1070
Total citations (3 years)
157
Citable documents (3 years)
167
Citations per document (2 years)
1
References per document
32.42
Source details
Match confidence
Probable — one matching ISSN
Matched via ISSN(s)
1812-9269
SCImago Source ID
29732
SCImago Rank (across all SCImago source types)
18744

Publication activity

Publication activity
2025
33 observed publications
Latest publication activity observed
2025
Current-year activity
Recent publication activity observed

Evidence sources: SCImago. SCImago's count is a source-reported aggregate figure; Crossref/OpenAlex/PubMed counts are distinct article records JCF Labs observed via each provider's own free API — none is guaranteed to be that journal's complete output for the year, and providers may disagree (this is expected, not an error). See this journal's own source evidence above for full context.

Subjects & categories

Subject area (SCImago)
MeSH (PubMed)
Neoplasms, Experimental
Scopus:1984-2026
MEDLINE:MEDLINE: v26n2, June 2004-; Index medicusIn: PubMed: v26n2, June 2004-;
PubMed:MEDLINE: v26n2, June 2004-; Index medicusIn: PubMed: v26n2, June 2004-;